ASX - By Stock
|
RHY |
Potential Australian market size for Colostat
|
|
josiejow37
|
11 |
3K |
6 |
28/02/23 |
28/02/23 |
ASX - By Stock
|
11
|
3K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
CanSense-CRC test (breakthrough)
|
|
josiejow37
|
14 |
3.5K |
5 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
14
|
3.5K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
JOSIEJOW37 says "Participation in any sort of poo handling test is stuck (literally!) in the low 40%s."
|
|
josiejow37
|
2 |
678 |
4 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
2
|
678
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
josiejow37
|
12 |
2.7K |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
12
|
2.7K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
23
|
4.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
23
|
4.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Who was it that said that gFOBT and FIT were the same?
|
|
josiejow37
|
2 |
527 |
2 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
2
|
527
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: RHY Institutional Presentation
|
|
josiejow37
|
32 |
7.8K |
3 |
24/02/23 |
24/02/23 |
ASX - By Stock
|
32
|
7.8K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Xmas 2023 share price predicition
|
|
josiejow37
|
24 |
5.2K |
5 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
24
|
5.2K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Xmas 2023 share price predicition
|
|
josiejow37
|
24 |
5.2K |
2 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
24
|
5.2K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Xmas 2023 share price predicition
|
|
josiejow37
|
24 |
5.2K |
3 |
23/02/23 |
23/02/23 |
ASX - By Stock
|
24
|
5.2K
|
3
|
|
ASX - By Stock
|
RHY |
Process for Colostat to be included in MBS (Medicare)
|
|
josiejow37
|
4 |
1.6K |
13 |
22/02/23 |
22/02/23 |
ASX - By Stock
|
4
|
1.6K
|
13
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
josiejow37
|
37 |
8.0K |
9 |
21/02/23 |
21/02/23 |
ASX - By Stock
|
37
|
8.0K
|
9
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Maintains ISO Certification
|
|
josiejow37
|
12 |
2.8K |
4 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
12
|
2.8K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Rhythm Maintains ISO Certification
|
|
josiejow37
|
12 |
2.8K |
7 |
20/02/23 |
20/02/23 |
ASX - By Stock
|
12
|
2.8K
|
7
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
josiejow37
|
37 |
8.0K |
2 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
37
|
8.0K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
IFOBT is here to stay for quite sometime.
|
|
josiejow37
|
37 |
8.0K |
4 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
37
|
8.0K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
1 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
23
|
4.8K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Increasing Screening Compliance for Colorectal Cancer
|
|
josiejow37
|
18 |
2.7K |
5 |
16/02/23 |
16/02/23 |
ASX - By Stock
|
18
|
2.7K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
2 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
23
|
4.8K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
5 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
23
|
4.8K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
6 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
23
|
4.8K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
3 |
15/02/23 |
15/02/23 |
ASX - By Stock
|
23
|
4.8K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
1 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
23
|
4.8K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
0 |
13/02/23 |
13/02/23 |
ASX - By Stock
|
23
|
4.8K
|
0
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
2 |
12/02/23 |
12/02/23 |
ASX - By Stock
|
23
|
4.8K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
6 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
23
|
4.8K
|
6
|
|
ASX - By Stock
|
RHY |
Participation Statistics - Australian National Bowel Cancer Screening Program
|
|
josiejow37
|
23 |
4.8K |
11 |
10/02/23 |
10/02/23 |
ASX - By Stock
|
23
|
4.8K
|
11
|
|
ASX - By Stock
|
RHY |
Re:
Insiders Who Sold AU$6.5m Of Rhythm Biosciences Made The Right Call
|
|
josiejow37
|
5 |
1.8K |
10 |
08/02/23 |
08/02/23 |
ASX - By Stock
|
5
|
1.8K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Commercialisation of Colostat
|
|
josiejow37
|
22 |
5.0K |
3 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
22
|
5.0K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
Commercialisation of Colostat
|
|
josiejow37
|
22 |
5.0K |
6 |
02/02/23 |
02/02/23 |
ASX - By Stock
|
22
|
5.0K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
TGA Decision
|
|
josiejow37
|
32 |
8.7K |
2 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
32
|
8.7K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
TGA Decision
|
|
josiejow37
|
32 |
8.7K |
1 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
32
|
8.7K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
TGA Decision
|
|
josiejow37
|
32 |
8.7K |
4 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
32
|
8.7K
|
4
|
|
ASX - By Stock
|
RHY |
Re:
TGA Decision
|
|
josiejow37
|
32 |
8.7K |
6 |
01/02/23 |
01/02/23 |
ASX - By Stock
|
32
|
8.7K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Appointment of New Non-Executive Director
|
|
josiejow37
|
8 |
2.4K |
5 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
8
|
2.4K
|
5
|
|
ASX - By Stock
|
RHY |
Re:
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
josiejow37
|
12 |
2.7K |
2 |
31/01/23 |
31/01/23 |
ASX - By Stock
|
12
|
2.7K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
josiejow37
|
12 |
2.7K |
1 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
12
|
2.7K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
3 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
74
|
19K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
3 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
74
|
19K
|
3
|
|
ASX - By Stock
|
RHY |
Re:
US based company with better results launching world wide
|
|
josiejow37
|
74 |
19K |
2 |
30/01/23 |
30/01/23 |
ASX - By Stock
|
74
|
19K
|
2
|
|
Charts
|
RHY |
Re:
RHY charts
|
|
josiejow37
|
80 |
45K |
2 |
29/01/23 |
29/01/23 |
Charts
|
80
|
45K
|
2
|
|
ASX - By Stock
|
RHY |
Sept '21 Deloitte's review of the National Bowel Cancer Screening Program
|
|
josiejow37
|
12 |
2.7K |
10 |
26/01/23 |
26/01/23 |
ASX - By Stock
|
12
|
2.7K
|
10
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
josiejow37
|
44 |
10K |
1 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
josiejow37
|
44 |
10K |
2 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
Ann: Institutional Presentation
|
|
josiejow37
|
44 |
10K |
2 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
44
|
10K
|
2
|
|
ASX - By Stock
|
RHY |
Re:
National Cancer Screening Register Bill 2016
|
|
josiejow37
|
3 |
832 |
5 |
25/01/23 |
25/01/23 |
ASX - By Stock
|
3
|
832
|
5
|
|
ASX - By Stock
|
RHY |
Re:
CellMax Life's FirstSight CRC Blood Test (DNA)
|
|
josiejow37
|
17 |
4.3K |
6 |
24/01/23 |
24/01/23 |
ASX - By Stock
|
17
|
4.3K
|
6
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
1 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
24
|
7.1K
|
1
|
|
ASX - By Stock
|
RHY |
Re:
Holiday Research - US competitive landscape and pan-cancer detection
|
|
josiejow37
|
24 |
7.1K |
1 |
23/01/23 |
23/01/23 |
ASX - By Stock
|
24
|
7.1K
|
1
|
|